$APOP News
Last published 3y ago
- 3y agoAPOPCellect, LLC vs Samsung Electronics Co., Ltd. - AIA Trial, AffirmedUS Patent Trial and Appeal Board
- 3y agoAPOPCellect, LLC vs Samsung Electronics Co., Ltd. - AIA Trial, AffirmedUS Patent Trial and Appeal Board
- 3y agoAPOPCellect, LLC vs Samsung Electronics Co., Ltd. - AIA Trial, AffirmedUS Patent Trial and Appeal Board
- 3y agoAPOPCellect, LLC vs Samsung Electronics Co., Ltd. - AIA Trial, AffirmedUS Patent Trial and Appeal Board
- 4y agoAPOPCELLECT, LLC et al. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 5y agoAPOPCellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin PharmaceuticalsGlobeNewswireTel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP") (the "Company"), announced today the record date and distribution date for the contingent value rights (the "CVRs") to be distributed in connection with the previo
- 5y agoAPOPCellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin PharmaceuticalsGlobeNewswireTel Aviv, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced shareholders voted to approve the previously announced strategic merger agreement with privately-held Quoin Pharmaceuticals, a specialty pharmaceutical
- 5y agoAPOPCEIDNNFBRX+1Thinking about buying stock in Meta Materials, Cellect Biotechnology, Forte Biosciences, Camber Energy, or Denison Mines?PR NewswireNEW YORK, Sept. 3, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MMAT, APOP, FBRX, CEI, and DNN. T
- 5y agoAPOPCellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.GlobeNewswireTel Aviv, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Reflecting continued clinical progress, Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced the first ApoGraftTM transplantation in a Leukemia patient in the Company's clinical trial at Washington Univ
- 5y agoAPOPCellect Biotechnology Reports Second Quarter 2021 Financial and Operating ResultsGlobeNewswireStrategic Merger Transaction Remains on Track to Close During the 2021 Third Quarter Tel Aviv, Israel, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology that enables the fun
- 5y agoAPOPThe Securities and Exchange Commission Declared Cellect Biotechnology's Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin PharmaceuticalsGlobeNewswireSpecial General Meeting of Shareholders Scheduled for September 19, 2021 Tel Aviv, Israel, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology that enables the functional selection of s
- 5y agoAPOPCTXREDUNOVN+1Thinking about buying stock in Citius Pharmaceuticals, New Oriental Education, Cellect Biotechnology, Novan, or Seanergy Maritime?PR NewswireNEW YORK, June 17, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CTXR, EDU, APOP, NOVN, and SHIP. T
- 5y agoAPOPCellect Biotechnology Files Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin PharmaceuticalsGlobeNewswireTel Aviv, Israel, June 16, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology that enables the functional selection of stem cells, announced today that it has filed a registration statement, inclu
- 5y agoAPOPCellect Biotechnology Reports Top Line Data from Phase 1/2 Clinical TrialGlobeNewswireTel Aviv, Israel, April 19, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology that enables the functional selection of stem cells, today announced positive data from the Company's open label Phas
- 5y agoAPOPCellect Biotechnology Reports Fourth Quarter and Full Year 2020 Financial and Operating ResultsGlobeNewswireTEL AVIV, Israel, March 29, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”), a developer of innovative technology that enables the functional selection of stem cells, today...
- 5y agoAPOPCellect Biotechnology and Quoin Pharmaceuticals Announce Strategic MergerGlobeNewswireUp to $25 million of funding at $75 million pre-money valuation to be available to the combined company concurrently with the merger Cellect shareholders to retain 25% of the combined...
- 5y agoAPOPCellect Biotechnology Reports Third Quarter Financial and Operating Results; Recent Developments Position Company to Accelerate Progress in 2021GlobeNewswirePromising Progress on Clinical Development Progress, Collaborations and Partnering Mutually Ended Discussion on Medical Cannabis Commercial and Merger Agreements TEL AVIV, Israel, Nov. 20, 2020 ...
- 6y agoAPOPCellect Biotechnology Commences Collaboration with XNK Therapeutics to Advance Novel NK Cell-Based Therapies; Adds Another Partner for its Functional Cell Selection TechnologyGlobeNewswireTel Aviv, Israel , Oct. 29, 2020 (GLOBE NEWSWIRE) -- Adding to a growing roster of partners, Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced that it has entered into and commenced a...
- 6y agoAPOPCellect Biotechnology Initiates U.S. Clinical Trial of ApoGraftGlobeNewswireTel Aviv, Israel , Oct. 22, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology which enables the functional selection of cells facilitating...
- 6y agoAPOPCellect Biotechnology to Present at the 2020 Cell & Gene Meeting on the MesaGlobeNewswireManagement to Highlight Progress in Bone Marrow Transplant (BMT) and Chimeric Antigen Receptor T Cell (CAR T) Business Collaborations Tel Aviv, Israel, Sept. 21, 2020 (GLOBE NEWSWIRE) --...
- 6y agoAPOPCellect Biotechnology Reports Second Quarter Financial and Operating Results; First Half 2020 Strategic Developments Create Long-Term Revenue CatalystsPR NewswireCellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported...
- 6y agoAPOPEuropean Patent Office Grants Cellect Biotechnology Pivotal Patent for Stem Cells ActivationPR NewswireCellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced ...
- 6y agoXAIRAPOPXTLBSeedo Corp. Appoints New Board of DirectorsGlobeNewswireYoqneam, Israel, July 01, 2020 (GLOBE NEWSWIRE) -- Seedo Corp. (OTC: SEDO) (“Seedo”) announced its shareholders have elected a new Board of Directors. The new Board brings decades of executive...
- 6y agoAPOPCellect Biotechnology Reports First Quarter 2020 Financial and Operating Results; Continues to Demonstrate Significant Progress Despite Adjusted Operations Due to COVID-19PR NewswireCellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported...
- 6y agoAPOPCellect Biotechnology's ApoGraft™ to Empower Cellular Treatment of COVID-19 Related Pulmonary DiseasesPR NewswireCellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced ...
- 6y agoAPOPCellect Biotechnology Announces Exercise of Warrants for Cash Proceeds of Approximately $1.5 MillionGlobeNewswireTEL AVIV, Israel, May 12, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today...
- 6y agoAPOPCellect Biotechnology Announces Positive Data Demonstrating Robust Engraftment Using ApoGraft was Featured in Bone Marrow Transplantation; Primary Data Points Were Submitted to the FDA During Investigational New Drug Approval ProcessPR NewswireCellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced ...
- 6y agoAPOPCellect Biotechnology Continues to Achieve Milestones; Receives New Patent Allowance in CanadaPR NewswireCellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, received an...
- 6y agoAPOPCellect Biotechnology Reports Fourth Quarter and Full Year 2019 ResultsPR NewswireCellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, today announced operating and financial results...
- 6y agoAPOPCellect Biotechnology Receives New Patent Allowance in ChinaPR NewswireCellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, received an...
- 6y agoAPOPCanndoc and Super-Pharm Sign Long-Term Partnership AgreementPR NewswireInterCure (TASE: INCR) announces today that wholly owned subsidiary, Canndoc, has entered into a strategic partnership agreement with Super-Pharm,...
- 6y agoAPOPCellect Biotechnology Ltd. Prices $3m Registered Direct Offering of American Depositary SharesPR NewswireCellect Biotechnology Ltd. (Nasdaq: APOP) ("Cellect" or the "Company"), a developer of innovative technology which enables the functional selection...
- 6y agoAPOPCellect Biotechnology Strengthens IP Portfolio; Receives "Intention to Grant" Patents from European and Israeli Patent OfficesPR NewswireCellect Biotechnology Ltd. (Nasdaq: APOP), a developer of innovative technology which enables the functional selection of stem cells, received...
- 6y agoAPOPCellect Biotechnology Receives Approval for U.S. Clinical TrialPR NewswireCellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology to enable the functional selection of stem cells, has received...
- 6y agoAPOPCellect Biotechnology Reports Third Quarter 2019 Financial and Operating ResultsPR NewswireCellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported...
- 7y agoAPOPCellect Biotechnology Regains Compliance With Nasdaq Minimum Bid Price RequirementPR NewswireCellect Biotechnology Ltd. (Nasdaq: APOP), a developer of innovative technology which enables the functional selection of stem cells, announced today ...
- 7y agoAPOPCellect Biotechnology Reports Second Quarter 2019 Financial and Operating ResultsPR NewswireCellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported...